News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Akorn, Inc. Reports 2009 Fourth Quarter and Year-End Financial Results
March 16, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LAKE FOREST, Ill.--(BUSINESS WIRE)--Akorn, Inc. (NASDAQ: AKRX), a niche generic pharmaceutical company, today reported financial results for the fourth quarter and year ended December 31, 2009.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Manufacturing
Roche Seeks Antibiotic Partner as Rising Manufacturing Costs Drive Supply Rethink
February 24, 2026
·
1 min read
·
Nick Paul Taylor
IPO tracker
Generate’s IPO Could Reach $425M, Largest Raise Yet
February 24, 2026
·
5 min read
·
Tristan Manalac
Manufacturing
AbbVie Backs Obesity Push With $380M API Production Expansion Project in Illinois
February 24, 2026
·
2 min read
·
Nick Paul Taylor
Manufacturing
Radiopharmaceutical Sector Shapes Supply Chain Around Fast-Decaying Products
February 24, 2026
·
3 min read
·
Nick Paul Taylor